Colin Hill

Insider Reports History

Entity
Individual
Location
196 Broadway, Cambridge, MA
Signature
/s/ Curt Oltmans as attorney-in-fact for Colin Hill
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Colin Hill:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Fulcrum Therapeutics, Inc. Director Stock Option (right to buy) 60K Jun 17, 2024 Direct
Fulcrum Therapeutics, Inc. Director No securities are beneficially owned 0 Jun 17, 2024 Direct
PPD, Inc. Director Common Stock 0 $47.50 Dec 8, 2021 Direct

Insider Reports Filed by Colin Hill

Symbol Company Period Transactions Value $ Form Type Date Filed Role
FULC Fulcrum Therapeutics, Inc. Jun 17, 2024 1 $0 4 Jun 18, 2024 Director
FULC Fulcrum Therapeutics, Inc. Jun 17, 2024 0 $0 3 Jun 18, 2024 Director
PPD PPD, Inc. Dec 8, 2021 1 -$776K 4 Dec 8, 2021 Director